Publications by authors named "Midori Hase"

Article Synopsis
  • Terbinafine (TRF) has been a common treatment for fungal infections for over 20 years, but TRF-resistant strains of fungi like Trichophyton interdigitale and T. rubrum have been found worldwide.
  • This study aimed to investigate TRF-resistant strains in Japanese patients by performing antifungal susceptibility testing on clinical isolates from various skin infections.
  • Out of 210 clinical isolates, five T. rubrum strains showed resistance to TRF, with significant mutations in the squalene epoxidase (SQLE) gene, indicating a connection between genetic changes and TRF resistance.
View Article and Find Full Text PDF

Ravuconazole (RVCZ) is a new human anti-fungal azole drug available in Japan since 2018 and is a broad-spectrum agent that exhibits excellent activity against dermatophytes. In the present study, the in vitro RVCZ susceptibility of clinical isolates of anthropophilic dermatophytes, including Trichophyton interdigitale strains with either low susceptibility to itraconazole (ITCZ) or resistance to terbinafine (TEBR), was investigated using the Clinical & Laboratory Standards Institute M38-A2 test. The MICs of RCVZ for 20 clinical isolates of T.

View Article and Find Full Text PDF

A 73-year-old male who had been receiving immunosuppressive drugs for 15 years developed a nodule on the left buttock region. The nodule slowly grew into a 15-cm fluctuant multilocular subcutaneous cyst. Serum beta-D-glucan levels were high, and the yellow purulent fluid obtained from the cyst was positive for Trichophyton rubrum.

View Article and Find Full Text PDF

Topical or systemic antifungal therapy was administered to patients diagnosed with Malassezia folliculitis during the 5-year period between March 2007 and October 2013. The diagnosis of Malassezia folliculitis was established on the basis of characteristic clinical features and direct microscopic findings (10 or more yeast-like fungi per follicle). Treatment consisted of topical application of 2% ketoconazole cream or 100 mg oral itraconazole based on symptom severity and patients' preferences.

View Article and Find Full Text PDF

A 41-year-old man visited our dermatology clinic because an eruption, which was resistant to steroid ointment treatment, had appeared on his right forearm. An oval, soybean-sized erythematous infiltrated lesion with scales and crusts was located in the central part of the extensor surface of the right forearm and showed partial erosion with attached yellow crusts. The lesion had an impetigo-like appearance.

View Article and Find Full Text PDF